Literature DB >> 23154099

Glutamate system genes and brain volume alterations in pediatric obsessive-compulsive disorder: a preliminary study.

Ke Wu1, Gregory L Hanna, Philip Easter, James L Kennedy, David R Rosenberg, Paul D Arnold.   

Abstract

Obsessive-compulsive disorder (OCD) has been associated with regional volumetric brain abnormalities, which provide promising intermediate phenotypes of the disorder. In this study, volumes of brain regions selected for a priori evidence of association with OCD (orbitofrontal cortex (OFC), anterior cingulate cortex (ACC), thalamus, caudate, putamen, globus pallidus and pituitary) were measured using structural magnetic resonance imaging (MRI) in 20 psychotropic-naïve pediatric OCD patients. We examined the association between these regional brain volumes and a total of 519 single nucleotide polymorphisms (SNPs) from nine glutamatergic candidate genes (DLGAP1, DLGAP2, DLGAP3, GRIN2B, SLC1A1, GRIK2, GRIK3, SLITRK1 and SLITRK5). These genes were selected based on either previous reported association with OCD in humans or evidence from animal models of OCD. After correcting for multiple comparisons by permutation testing, no SNP remained significantly associated with volumetric changes. The strongest trend toward association was identified between two SNPs in DLGAP2 (rs6558484 and rs7014992) and OFC white matter volume. Our other top ranked association findings were with ACC, OFC and thalamus. These preliminary results suggest that sequence variants in glutamate candidate genes may be associated with structural neuroimaging phenotypes of OCD.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23154099      PMCID: PMC4552325          DOI: 10.1016/j.pscychresns.2012.07.003

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  52 in total

1.  Decrease in thalamic volumes of pediatric patients with obsessive-compulsive disorder who are taking paroxetine.

Authors:  A R Gilbert; G J Moore; M S Keshavan; L A Paulson; V Narula; F P Mac Master; C M Stewart; D R Rosenberg
Journal:  Arch Gen Psychiatry       Date:  2000-05

2.  Frontostriatal measurement in treatment-naive children with obsessive-compulsive disorder.

Authors:  D R Rosenberg; M S Keshavan; K M O'Hearn; E L Dick; W W Bagwell; A B Seymour; D M Montrose; J N Pierri; B Birmaher
Journal:  Arch Gen Psychiatry       Date:  1997-09

3.  Pituitary volume in pediatric obsessive-compulsive disorder.

Authors:  Frank P MacMaster; Aileen Russell; Yousha Mirza; Matcheri S Keshavan; S Preeya Banerjee; Rashmi Bhandari; Courtney Boyd; Michelle Lynch; Michelle Rose; Jennifer Ivey; Gregory J Moore; David R Rosenberg
Journal:  Biol Psychiatry       Date:  2005-09-02       Impact factor: 13.382

4.  Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

5.  MRI assessment of children with obsessive-compulsive disorder or tics associated with streptococcal infection.

Authors:  J N Giedd; J L Rapoport; M A Garvey; S Perlmutter; S E Swedo
Journal:  Am J Psychiatry       Date:  2000-02       Impact factor: 18.112

6.  A transgenic model of comorbid Tourette's syndrome and obsessive-compulsive disorder circuitry.

Authors:  E J Nordstrom; F H Burton
Journal:  Mol Psychiatry       Date:  2002       Impact factor: 15.992

7.  Association of the SLC1A1 glutamate transporter gene and obsessive-compulsive disorder.

Authors:  S Evelyn Stewart; Jesen A Fagerness; Jill Platko; Jordan W Smoller; Jeremiah M Scharf; Cornelia Illmann; Eric Jenike; Nadia Chabane; Marion Leboyer; Richard Delorme; Michael A Jenike; David L Pauls
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2007-12-05       Impact factor: 3.568

Review 8.  Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: the orbitofronto-striatal model revisited.

Authors:  Lara Menzies; Samuel R Chamberlain; Angela R Laird; Sarah M Thelen; Barbara J Sahakian; Ed T Bullmore
Journal:  Neurosci Biobehav Rev       Date:  2007-10-17       Impact factor: 8.989

9.  Slitrk5 deficiency impairs corticostriatal circuitry and leads to obsessive-compulsive-like behaviors in mice.

Authors:  Sergey V Shmelkov; Adília Hormigo; Deqiang Jing; Catia C Proenca; Kevin G Bath; Till Milde; Evgeny Shmelkov; Jared S Kushner; Muhamed Baljevic; Iva Dincheva; Andrew J Murphy; David M Valenzuela; Nicholas W Gale; George D Yancopoulos; Ipe Ninan; Francis S Lee; Shahin Rafii
Journal:  Nat Med       Date:  2010-04-25       Impact factor: 53.440

10.  Genome-wide association study of obsessive-compulsive disorder.

Authors:  S E Stewart; D Yu; J M Scharf; B M Neale; J A Fagerness; C A Mathews; P D Arnold; P D Evans; E R Gamazon; L K Davis; L Osiecki; L McGrath; S Haddad; J Crane; D Hezel; C Illman; C Mayerfeld; A Konkashbaev; C Liu; A Pluzhnikov; A Tikhomirov; C K Edlund; S L Rauch; R Moessner; P Falkai; W Maier; S Ruhrmann; H-J Grabe; L Lennertz; M Wagner; L Bellodi; M C Cavallini; M A Richter; E H Cook; J L Kennedy; D Rosenberg; D J Stein; S M J Hemmings; C Lochner; A Azzam; D A Chavira; E Fournier; H Garrido; B Sheppard; P Umaña; D L Murphy; J R Wendland; J Veenstra-VanderWeele; D Denys; R Blom; D Deforce; F Van Nieuwerburgh; H G M Westenberg; S Walitza; K Egberts; T Renner; E C Miguel; C Cappi; A G Hounie; M Conceição do Rosário; A S Sampaio; H Vallada; H Nicolini; N Lanzagorta; B Camarena; R Delorme; M Leboyer; C N Pato; M T Pato; E Voyiaziakis; P Heutink; D C Cath; D Posthuma; J H Smit; J Samuels; O J Bienvenu; B Cullen; A J Fyer; M A Grados; B D Greenberg; J T McCracken; M A Riddle; Y Wang; V Coric; J F Leckman; M Bloch; C Pittenger; V Eapen; D W Black; R A Ophoff; E Strengman; D Cusi; M Turiel; F Frau; F Macciardi; J R Gibbs; M R Cookson; A Singleton; J Hardy; A T Crenshaw; M A Parkin; D B Mirel; D V Conti; S Purcell; G Nestadt; G L Hanna; M A Jenike; J A Knowles; N Cox; D L Pauls
Journal:  Mol Psychiatry       Date:  2012-08-14       Impact factor: 15.992

View more
  25 in total

1.  Genetic variability in scaffolding proteins and risk for schizophrenia and autism-spectrum disorders: a systematic review.

Authors:  Jordi Soler; Lourdes Fañanás; Mara Parellada; Marie-Odile Krebs; Guy A Rouleau; Mar Fatjó-Vilas
Journal:  J Psychiatry Neurosci       Date:  2018-05-28       Impact factor: 6.186

2.  Significant concordance of genetic variation that increases both the risk for obsessive-compulsive disorder and the volumes of the nucleus accumbens and putamen.

Authors:  Derrek P Hibar; Joshua W Cheung; Sarah E Medland; Mary S Mufford; Neda Jahanshad; Shareefa Dalvie; Raj Ramesar; Evelyn Stewart; Odile A van den Heuvel; David L Pauls; James A Knowles; Dan J Stein; Paul M Thompson
Journal:  Br J Psychiatry       Date:  2018-07       Impact factor: 9.319

3.  Genetic variability in scaffolding proteins and risk for schizophrenia and autism-spectrum disorders: a systematic review.

Authors:  Jordi Soler; Lourdes Fañanás; Mara Parellada; Marie-Odile Krebs; Guy A Rouleau; Mar Fatjó-Vilas
Journal:  J Psychiatry Neurosci       Date:  2018-07       Impact factor: 6.186

Review 4.  The importance of the excitatory amino acid transporter 3 (EAAT3).

Authors:  Walden E Bjørn-Yoshimoto; Suzanne M Underhill
Journal:  Neurochem Int       Date:  2016-05-24       Impact factor: 3.921

5.  MicroRNA Alterations in Induced Pluripotent Stem Cell-Derived Neurons from Bipolar Disorder Patients: Pathways Involved in Neuronal Differentiation, Axon Guidance, and Plasticity.

Authors:  Monica Bame; Melvin G McInnis; K Sue O'Shea
Journal:  Stem Cells Dev       Date:  2020-06-17       Impact factor: 3.272

Review 6.  Cross-generational THC exposure alters the developmental sensitivity of ventral and dorsal striatal gene expression in male and female offspring.

Authors:  Henrietta Szutorisz; Gabor Egervári; James Sperry; Jenna M Carter; Yasmin L Hurd
Journal:  Neurotoxicol Teratol       Date:  2016-05-21       Impact factor: 3.763

7.  Lower excitatory synaptic gene expression in orbitofrontal cortex and striatum in an initial study of subjects with obsessive compulsive disorder.

Authors:  Sean C Piantadosi; Brittany L Chamberlain; Jill R Glausier; David A Lewis; Susanne E Ahmari
Journal:  Mol Psychiatry       Date:  2019-06-05       Impact factor: 15.992

8.  8p23.2-pter Microdeletions: Seven New Cases Narrowing the Candidate Region and Review of the Literature.

Authors:  Ilaria Catusi; Maria Garzo; Anna Paola Capra; Silvana Briuglia; Chiara Baldo; Maria Paola Canevini; Rachele Cantone; Flaviana Elia; Francesca Forzano; Ornella Galesi; Enrico Grosso; Michela Malacarne; Angela Peron; Corrado Romano; Monica Saccani; Lidia Larizza; Maria Paola Recalcati
Journal:  Genes (Basel)       Date:  2021-04-27       Impact factor: 4.096

9.  Glutamate Genetics in Obsessive-Compulsive Disorder: A Review.

Authors:  Rageen Rajendram; Sefi Kronenberg; Christie L Burton; Paul D Arnold
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2017-10-01

Review 10.  Psychotropic treatments in Prader-Willi syndrome: a critical review of published literature.

Authors:  O Bonnot; D Cohen; D Thuilleaux; A Consoli; S Cabal; M Tauber
Journal:  Eur J Pediatr       Date:  2015-11-19       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.